CN107567494A - 间充质干细胞的细胞培养方法 - Google Patents

间充质干细胞的细胞培养方法 Download PDF

Info

Publication number
CN107567494A
CN107567494A CN201680025469.8A CN201680025469A CN107567494A CN 107567494 A CN107567494 A CN 107567494A CN 201680025469 A CN201680025469 A CN 201680025469A CN 107567494 A CN107567494 A CN 107567494A
Authority
CN
China
Prior art keywords
culture medium
pdgf
cell culture
level
fgf2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680025469.8A
Other languages
English (en)
Chinese (zh)
Inventor
P·西蒙斯
C·叙尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mesoblast International SARL
Original Assignee
Mesoblast International SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015900752A external-priority patent/AU2015900752A0/en
Application filed by Mesoblast International SARL filed Critical Mesoblast International SARL
Priority to CN202111251410.XA priority Critical patent/CN113957043A/zh
Publication of CN107567494A publication Critical patent/CN107567494A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/115—Platelets, megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN201680025469.8A 2015-03-04 2016-03-04 间充质干细胞的细胞培养方法 Pending CN107567494A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111251410.XA CN113957043A (zh) 2015-03-04 2016-03-04 间充质干细胞的细胞培养方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2015900752 2015-03-04
AU2015900752A AU2015900752A0 (en) 2015-03-04 Cell culture method
AU2015900777A AU2015900777A0 (en) 2015-03-05 Cell culture method
AU2015900777 2015-03-05
PCT/EP2016/054640 WO2016139340A1 (en) 2015-03-04 2016-03-04 Cell culture method for mesenchymal stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202111251410.XA Division CN113957043A (zh) 2015-03-04 2016-03-04 间充质干细胞的细胞培养方法

Publications (1)

Publication Number Publication Date
CN107567494A true CN107567494A (zh) 2018-01-09

Family

ID=55453191

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201680025469.8A Pending CN107567494A (zh) 2015-03-04 2016-03-04 间充质干细胞的细胞培养方法
CN202111251410.XA Pending CN113957043A (zh) 2015-03-04 2016-03-04 间充质干细胞的细胞培养方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202111251410.XA Pending CN113957043A (zh) 2015-03-04 2016-03-04 间充质干细胞的细胞培养方法

Country Status (10)

Country Link
US (4) US20180037867A1 (https=)
EP (2) EP3265554B1 (https=)
JP (3) JP6885870B2 (https=)
KR (1) KR102635212B1 (https=)
CN (2) CN107567494A (https=)
AU (2) AU2016227607B2 (https=)
BR (1) BR112017018885A2 (https=)
CA (1) CA2977578C (https=)
SG (1) SG11201706886PA (https=)
WO (1) WO2016139340A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624554A (zh) * 2018-05-14 2018-10-09 山东大学 一种非基因修饰光操控双向调节人脐带间充质干细胞增殖的方法
CN115997005A (zh) * 2020-06-11 2023-04-21 迈索布拉斯特国际有限公司 间充质谱系前体或干细胞的3d培养

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2982461T3 (es) 2008-09-16 2024-10-16 Mayo Found Medical Education & Res Composiciones que contienen contenido plaquetario
US20120087933A1 (en) 2010-10-08 2012-04-12 Samson Tom Enhanced msc preparations
US11891620B2 (en) 2014-05-16 2024-02-06 Mayo Foundation For Medical Education And Research Cell culture media compositions for primary cells
CN107567494A (zh) 2015-03-04 2018-01-09 迈索布拉斯特国际有限公司 间充质干细胞的细胞培养方法
CN119033819A (zh) 2017-11-22 2024-11-29 迈索布拉斯特国际有限公司 细胞组合物及治疗方法
CN108251358B (zh) * 2017-12-15 2021-10-26 广东药科大学 一种相同供体来源人间充质干细胞的多批次原代分离方法
SG11202009393QA (en) * 2018-03-28 2020-10-29 Pluristem Ltd Methods for expanding adherent stromal cells and cells obtained thereby
US11364323B2 (en) 2018-09-17 2022-06-21 Rejuvablast LLC Combination grafts for tissue repair or regeneration applications
WO2020067443A1 (ja) * 2018-09-27 2020-04-02 テルモ株式会社 体細胞のシート化方法
CN117396077A (zh) * 2021-03-10 2024-01-12 寺崎生物医学创新研究所 用于实验室生长肉和其他应用的生长因子
WO2022192429A1 (en) * 2021-03-10 2022-09-15 Terasaki Insutitute For Biomedical Innovation Constructs comprising fibrin or other blood products for meat cultivation and other applications
EP4630017A1 (en) 2022-12-09 2025-10-15 Mesoblast International Sàrl Method of treating heart failure in subjects with persistent inflammation
AU2023389701A1 (en) 2022-12-09 2025-07-10 Mesoblast International Sarl Method of treating inflammation with cellular compositions
AU2023389702A1 (en) 2022-12-09 2025-07-10 Mesoblast International Sarl Pre-licensed composition and cell culture methods
CN120603930A (zh) 2022-12-09 2025-09-05 迈索布拉斯特国际有限公司 条件培养基及其用途
WO2024225602A1 (ko) * 2023-04-24 2024-10-31 파미셀 주식회사 뉴클레오시드 함유 세포 배양배지 및 이를 이용한 세포 배양 방법
AU2024332651A1 (en) 2023-08-28 2026-04-02 Mesoblast International Sàrl Third line treatment for gvhd
WO2025062365A1 (en) 2023-09-22 2025-03-27 Mesoblast International Sárl Mesenchymal lineage precursor or stem cells (mlpscs) for use in methods of treating congenital heart disease

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008148643A (ja) * 2006-12-19 2008-07-03 Olympus Corp 無血清培地および幹細胞の培養方法
US20090232777A1 (en) * 2006-03-01 2009-09-17 Evy Lundgren-Akerlund Expansion and Differentiation of Mesenchymal Stem Cells
WO2011116117A2 (en) * 2010-03-18 2011-09-22 Wisconsin Alumni Research Foundation Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
CN102791276A (zh) * 2010-03-10 2012-11-21 智再如股份有限公司 含有间充质干细胞的细胞制品及其制造方法
CN103068969A (zh) * 2010-06-17 2013-04-24 思迪公司 化学成分确定的无血清细胞培养基
CN103396984A (zh) * 2013-07-25 2013-11-20 宗兆文 一种利用皮肤来源的祖细胞制备组织工程脊髓的方法
CN103687941A (zh) * 2011-01-12 2014-03-26 城户常雄 获得和维持易于在体外分化成少突胶质细胞谱系细胞的纯化或富集的哺乳动物神经干细胞群和/或神经祖细胞群的培养方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
WO1993003679A1 (de) 1991-08-12 1993-03-04 Karl Storz Gmbh & Co. Hochfrequenzchirurgiegenerator zum geregelten schneiden und koagulieren
US5814464A (en) 1994-10-07 1998-09-29 Regeneron Pharma Nucleic acids encoding TIE-2 ligand-2
US6277372B1 (en) 1994-11-08 2001-08-21 Diacrin, Inc. Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
US6204053B1 (en) 1994-11-08 2001-03-20 Diacrin, Inc. Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
WO1996031598A1 (en) 1995-04-06 1996-10-10 Regeneron Pharmaceuticals, Inc. Tie-2 ligands, methods of making and uses thereof
CA2277278A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
JP2002529071A (ja) * 1998-11-09 2002-09-10 コンソルツィオ・ペール・ラ・ジェスティオーネ・デル・チェントロ・ディ・ビオテクノロジー・アヴァンツァテ 軟骨細胞様細胞のための無血清培地
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AU2118501A (en) 1999-10-20 2001-04-30 Stemcells, Inc. Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
EP2316918B1 (en) 2001-02-14 2015-07-01 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
ES2432493T3 (es) 2001-02-14 2013-12-03 Anthrogenesis Corporation Placenta de mamífero post-parto, su uso y células madre de la misma
CA2458575C (en) 2001-08-24 2014-07-08 Advanced Cell Technology, Inc. Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
NZ534643A (en) 2002-02-13 2010-06-25 Anthrogenesis Corp Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
WO2003102134A2 (en) 2002-05-28 2003-12-11 Becton, Dickinson And Company Pancreatic acinar cells into insulin producing cells
CN1668324A (zh) 2002-05-28 2005-09-14 诺沃塞尔公司 用于胰岛素产生细胞的方法、组合物及生长与分化因子
EP2399990B1 (en) 2003-06-27 2015-07-22 DePuy Synthes Products, Inc. Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system
US8491883B2 (en) 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
KR100840979B1 (ko) 2004-02-26 2008-06-24 리라이언스 라이프 사이언시스 프라이빗. 리미티드 각막 윤부에서 유도된 다능성 배아 유사 줄기 세포, 분리방법 및 이들의 용도
EP1838842A2 (en) 2004-12-23 2007-10-03 Ethicon, Incorporated Treatment of osteochondral diseases using postpartum-derived cells and products thereof
CA2589041C (en) 2004-12-23 2019-08-20 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
EP1835924B1 (en) 2004-12-23 2013-08-21 Ethicon, Incorporated Treatment of parkinson's disease and related disorders using postpartum derived cells
EP1831355A2 (en) 2004-12-23 2007-09-12 Ethicon, Inc. Soft tissue repair and regeneration using postpartum-derived cells and cell products
BRPI0617085A2 (pt) 2005-09-02 2016-11-08 Agency Science Tech & Res método para obter uma célula-tronco mesenquimal (msc), célula ou linhagem celular, método para derivar uma cultura celular a partir de uma célula-tronco embrionária, método para tratamento de uma doença, uso de uma célula-tronco mesenquimal, linhagem diferenciada, composição farmacêutica, método para condicionar um meio de cultura celular, meio condicionado e uso do mesmo, mpetodo para obterum polipeptídeo, método para obtar uma cultura celular, cultura celular, célula-tronco mesenquimal, linhagem de célula-tronco mesenquimal ou uma célula mesenquimal diferenciada
JP4385076B2 (ja) * 2006-01-13 2009-12-16 独立行政法人科学技術振興機構 動物細胞を無血清培養するための培地用添加剤、キット及びこれらの利用
EP2617428A1 (en) * 2006-08-15 2013-07-24 Agency for Science, Technology and Research Mesenchymal stem cell conditioned medium
NZ612888A (en) 2007-02-12 2015-02-27 Anthrogenesis Corp Treatment of inflammatory diseases using placental stem cells
WO2008151390A1 (en) 2007-06-15 2008-12-18 Australian Stem Cell Centre Ltd Differentiation of human embryonic stem cells
KR101224588B1 (ko) * 2008-01-24 2013-01-22 삼성전자주식회사 멀티포인트 스트록을 감지하기 위한 ｕｉ 제공방법 및 이를적용한 멀티미디어 기기
US20110110888A1 (en) 2008-06-27 2011-05-12 Hai-Qing Xian Scaffold Coated and/or Impregnated with at Least One Bioactive Agent for Tissue Repair and Other Medical Applications
US20100055078A1 (en) * 2008-08-15 2010-03-04 The Government of the U.S.A, as represented by the Department of Veterans Affairs Methods of making a transplantable bone repair system using multipotent stem cells
KR101712501B1 (ko) 2008-11-11 2017-03-07 고쿠리츠다이가쿠호진 히로시마다이가쿠 분화 유도 배지용 첨가제 및 그의 용도
US20100158878A1 (en) 2008-12-23 2010-06-24 Alexandra Capela Target populations of oligodendrocyte precursor cells and methods of making and using same
US10894944B2 (en) 2009-04-10 2021-01-19 Monash University Cell culture media
KR101523040B1 (ko) * 2012-06-26 2015-05-26 라정찬 고농도의 줄기세포 제조방법
WO2014082685A1 (en) * 2012-11-30 2014-06-05 Swiss Stem Cell Foundation Serum-free medium for human mesenchymal stem cells
CN107567494A (zh) 2015-03-04 2018-01-09 迈索布拉斯特国际有限公司 间充质干细胞的细胞培养方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090232777A1 (en) * 2006-03-01 2009-09-17 Evy Lundgren-Akerlund Expansion and Differentiation of Mesenchymal Stem Cells
JP2008148643A (ja) * 2006-12-19 2008-07-03 Olympus Corp 無血清培地および幹細胞の培養方法
CN102791276A (zh) * 2010-03-10 2012-11-21 智再如股份有限公司 含有间充质干细胞的细胞制品及其制造方法
WO2011116117A2 (en) * 2010-03-18 2011-09-22 Wisconsin Alumni Research Foundation Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
CN103068969A (zh) * 2010-06-17 2013-04-24 思迪公司 化学成分确定的无血清细胞培养基
CN103687941A (zh) * 2011-01-12 2014-03-26 城户常雄 获得和维持易于在体外分化成少突胶质细胞谱系细胞的纯化或富集的哺乳动物神经干细胞群和/或神经祖细胞群的培养方法
CN103396984A (zh) * 2013-07-25 2013-11-20 宗兆文 一种利用皮肤来源的祖细胞制备组织工程脊髓的方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624554A (zh) * 2018-05-14 2018-10-09 山东大学 一种非基因修饰光操控双向调节人脐带间充质干细胞增殖的方法
CN108624554B (zh) * 2018-05-14 2021-09-14 山东大学 一种非基因修饰光操控双向调节人脐带间充质干细胞增殖的方法
CN115997005A (zh) * 2020-06-11 2023-04-21 迈索布拉斯特国际有限公司 间充质谱系前体或干细胞的3d培养

Also Published As

Publication number Publication date
CA2977578A1 (en) 2016-09-09
AU2016227607B2 (en) 2021-09-30
SG11201706886PA (en) 2017-09-28
JP2021090463A (ja) 2021-06-17
JP2024001179A (ja) 2024-01-09
EP3265554B1 (en) 2021-11-17
WO2016139340A1 (en) 2016-09-09
US20200040303A1 (en) 2020-02-06
BR112017018885A2 (pt) 2018-04-17
AU2016227607A1 (en) 2017-09-07
US20250129337A1 (en) 2025-04-24
US12215352B2 (en) 2025-02-04
AU2021254538A1 (en) 2021-11-18
JP7410899B2 (ja) 2024-01-10
US20180037867A1 (en) 2018-02-08
KR20170120627A (ko) 2017-10-31
AU2021254538B2 (en) 2024-01-18
US20240191200A1 (en) 2024-06-13
EP3265554A1 (en) 2018-01-10
JP2018506986A (ja) 2018-03-15
KR102635212B1 (ko) 2024-02-13
US11685899B2 (en) 2023-06-27
EP4008775A1 (en) 2022-06-08
CN113957043A (zh) 2022-01-21
CA2977578C (en) 2024-09-10
JP6885870B2 (ja) 2021-06-16

Similar Documents

Publication Publication Date Title
JP7410899B2 (ja) 間葉系幹細胞の細胞培養法
JP7571109B2 (ja) 改善された幹細胞組成物
Kang et al. Differentiating characterization of human umbilical cord blood‐derived mesenchymal stem cells in vitro
BR112014020119A2 (pt) cultura de células-tronco mesenquimais
Harkness et al. Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential
HK40074091A (en) Cell culture method for mesenchymal stem cells
US8216838B2 (en) Method for efficient production of monocyte-derived multipotent cell (MOMC)
HK1240971B (en) Cell culture method for mesenchymal stem cells
BR122024005049A2 (pt) Método de cultura celular para células-tronco mesenquimais

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination